Inactive Instrument

Analyst Reco. Seagen Inc.

Equities

SGEN

US81181C1045

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

Euphoria subsides for Triple-Witching Day	Dec. 15
ANALYST RECOMMENDATIONS : Adobe, Blackrock, Roblox, Snap, US Bancorp...	Dec. 15
Seagen Says Hodgkin Lymphoma Therapy Showed 98% Overall Response Rate in Phase 2 Trial	23-06-13	MT
Seagen Announces ADCETRIS® (brentuximab vedotin) Plus Novel Immunotherapy Combination Delivers 98% Overall Response Rate and 93% Complete Response Rate in Patients with Early-Stage Classical Hodgkin Lymphoma	23-06-13	CI
FTSE 100 in the green ahead of Fed rate decision	23-05-03	AN
Global dealmaking sinks to lowest level in over a decade	23-03-31	RE
Berenberg Bank Downgrades Seagen to Hold From Buy, Adjusts Price Target to $229 From $170	23-03-24	MT
TD Cowen Raises Price Target on Seagen to $229 From $145, Maintains Market Perform Rating	23-03-21	MT
Truist Securities Adjusts Price Target on Seagen to $229 From $152, Maintains Hold Rating	23-03-20	MT
The Week in Numbers: banking on a bailout	23-03-17	RE
The Week in Numbers: banking on a bailout	23-03-17	RE
Fitch Revises Pfizer's Outlook to Stable; Affirms IDR at 'A'	23-03-16	AQ
Factbox-US government to impose inflation penalties on 27 drugs	23-03-15	RE
Not out of the woods yet	23-03-15
Morgan Stanley Downgrades Seagen to Equalweight From Overweight, Adjusts Price Target to $229 From $173	23-03-15	MT
ANALYST RECOMMENDATIONS : AstraZeneca, Charles Schwab, Harley-Davidson, Meta Platforms, Seagen...	23-03-15
Investors are starting to dream about rate cuts	23-03-14
Oppenheimer Adjusts Seagen Price Target to $229 From $210, Maintains Outperform Rating	23-03-14	MT
Needham Downgrades Seagen to Hold From Buy	23-03-14	MT
RBC Boosts Price Target on Seagen to $229 From $155, Maintains Outperform Rating	23-03-14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Seagen Inc.

Equities

SGEN

US81181C1045

Analyst Reco.

Filters